Literature DB >> 18666309

Substitute consent for nursing home residents prescribed psychotropic medication.

Nicola Rendina1, Henry Brodaty, Brian Draper, Carmelle Peisah, Esteve Brugue.   

Abstract

BACKGROUND: Prescribing psychotropic medications for persons with dementia who lack capacity to give informed consent requires proxy consent under NSW Guardianship legislation.
OBJECTIVE: To survey current practice in complying with legislation and regulations in prescribing psychotropic medications for nursing home residents.
METHOD: In three Sydney nursing homes, the files of 77 residents identified as having dementia, being on a psychotropic medication and not having capacity to give informed consent, were audited.
RESULTS: In only 6.5% of cases were all regulations adhered to; a further 6.5% attempted and partially completed substitute consent requirements. The problem and the nature of the treatment were documented in 70.1% of cases. In 16.9% of files the only documentation of the prescribed medication was in the medication chart. Doses of medications prescribed were within accepted guidelines.
CONCLUSION: Current regulations and legislation are not being observed. Recommendations are made as to how to make them more practicable.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18666309     DOI: 10.1002/gps.2094

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  5 in total

Review 1.  Approaches to Deprescribing Psychotropic Medications for Changed Behaviours in Long-Term Care Residents Living with Dementia.

Authors:  Stephanie L Harrison; Monica Cations; Tiffany Jessop; Sarah N Hilmer; Mouna Sawan; Henry Brodaty
Journal:  Drugs Aging       Date:  2019-02       Impact factor: 3.923

2.  An Ageing Population Creates New Challenges Around Consent to Medical Treatment.

Authors:  Alice L Holmes; Joseph E Ibrahim
Journal:  J Bioeth Inq       Date:  2021-07-05       Impact factor: 1.352

3.  The development and testing of the quality use of medications in dementia (QUM-D): a tool for quality prescribing for behavioral and psychological symptoms of dementia (BPSD).

Authors:  Carmelle Peisah; Julie-Anne Strukovski; Chanaka Wijeratne; Rosalind Mulholland; Georgina Luscombe; Henry Brodaty
Journal:  Int Psychogeriatr       Date:  2015-02-02       Impact factor: 3.878

4.  Pharmacotherapy of Persons with Dementia in Long-Term Care in Australia: A Descriptive Audit of Central Nervous System Medications.

Authors:  Wendy Moyle; Najwan El Saifi; Brian Draper; Cindy Jones; Elizabeth Beattie; David Shum; Lukman Thalib; Cindy Mervin; Siobhan O Dwyer
Journal:  Curr Drug Saf       Date:  2017-02-09

5.  A missed opportunity to improve practice around the use of restraints and consent in residential aged care: Limitations of the Quality of Care Amendment (Minimising the Use of Restraints) Principles 2019.

Authors:  Carmelle Peisah; Tiffany Jessop; Juanita Breen
Journal:  Australas J Ageing       Date:  2019-12-05       Impact factor: 2.111

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.